We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It... Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. Show more
PRINCETON, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines...
SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...
SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...
SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...
SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...
="/Images/box-unchecked.jpg" alt="Checkbox not checked">750003/05/2024Cash* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the...
="/Images/box-checked.jpg" alt="Checkbox checked">144: Remarks and SignatureRemarksDate of Notice03/04/2024Date of Plan Adoption or Giving of Instruction, If Relying on Rule...
="/Images/box-unchecked.jpg" alt="Checkbox not checked">1583303/01/2024Cash* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.3 | -2.48344370861 | 12.08 | 12.24 | 11.32 | 1951184 | 11.63280936 | CS |
4 | -1.37 | -10.4182509506 | 13.15 | 13.595 | 11.32 | 3362376 | 12.07962585 | CS |
12 | -1.82 | -13.3823529412 | 13.6 | 14.09 | 11.32 | 3143348 | 12.75058737 | CS |
26 | -0.93 | -7.31707317073 | 12.71 | 14.57 | 9.7 | 3048590 | 12.16999997 | CS |
52 | 0.6 | 5.36672629696 | 11.18 | 14.57 | 9.7 | 2722194 | 12.27895446 | CS |
156 | 2.19 | 22.8362877998 | 9.59 | 14.57 | 5.91 | 2695491 | 10.89458546 | CS |
260 | -1.44 | -10.8925869894 | 13.22 | 25.39 | 5.91 | 2720786 | 11.63728522 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions